Literature DB >> 15788776

Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment.

Stephen P Hack1, Elena E Bagley, Billy C H Chieng, MacDonald J Christie.   

Abstract

Delta-opioid receptor (DOPr) activation fails to produce cellular physiological responses in many brain regions, including the periaqueductal gray (PAG), despite neural expression of high densities of the receptor. Previous histochemical studies have demonstrated that a variety of stimuli, including chronic morphine treatment, induce the translocation of DOPr from intracellular pools to the surface membrane of CNS neurons. PAG neurons in slices taken from untreated mice exhibited mu-opioid receptor (MOPr) but not DOPr-mediated presynaptic inhibition of GABAergic synaptic currents. In contrast, after 5-6 d of chronic morphine treatment, DOPr stimulation inhibited synaptic GABA release onto most neurons. Shorter exposure to morphine in vitro (upto 4 h) or in vivo (18 h) did not induce functional DOPr responses. DOPr-mediated presynaptic inhibition could not be induced in slices from untreated animals by increasing synaptic activity in vitro using high extracellular potassium concentrations or activation of protein kinase A. Induction of functional DOPr signaling by chronic morphine required MOPr expression, because no DOPr receptor responses were observed in MOPr knock-out mice. DOPr agonists also had no effect on miniature IPSCs in beta-arrestin-2 knock-out mice after chronic morphine. These results suggest that induction of DOPr-mediated actions in PAG by chronic morphine requires prolonged MOPr stimulation and expression of beta-arrestin-2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15788776      PMCID: PMC6725095          DOI: 10.1523/JNEUROSCI.4585-04.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  45 in total

Review 1.  Pharmacological chaperones: a new twist on receptor folding.

Authors:  J P Morello; U E Petäjä-Repo; D G Bichet; M Bouvier
Journal:  Trends Pharmacol Sci       Date:  2000-12       Impact factor: 14.819

Review 2.  Molecular mechanisms and regulation of opioid receptor signaling.

Authors:  P Y Law; Y H Wong; H H Loh
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

3.  Heterodimerization of mu and delta opioid receptors: A role in opiate synergy.

Authors:  I Gomes; B A Jordan; A Gupta; N Trapaidze; V Nagy; L A Devi
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

4.  Enhanced morphine analgesia in mice lacking beta-arrestin 2.

Authors:  L M Bohn; R J Lefkowitz; R R Gainetdinov; K Peppel; M G Caron; F T Lin
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

5.  Lesions of the dorsolateral funiculus block supraspinal opioid delta receptor mediated antinociception in the rat.

Authors:  C J Kovelowski; M H Ossipov; V J Hruby; F Porreca
Journal:  Pain       Date:  1999-11       Impact factor: 6.961

Review 6.  What peptides these deltorphins be.

Authors:  L H Lazarus; S D Bryant; P S Cooper; S Salvadori
Journal:  Prog Neurobiol       Date:  1999-02       Impact factor: 11.685

7.  Stimulus-dependent translocation of kappa opioid receptors to the plasma membrane.

Authors:  S J Shuster; M Riedl; X Li; L Vulchanova; R Elde
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

8.  Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1.

Authors:  A G Schuller; M A King; J Zhang; E Bolan; Y X Pan; D J Morgan; A Chang; M E Czick; E M Unterwald; G W Pasternak; J E Pintar
Journal:  Nat Neurosci       Date:  1999-02       Impact factor: 24.884

9.  An autoradiographic study in mu-opioid receptor knockout mice.

Authors:  H Chen; V S Seybold; H H Loh
Journal:  Brain Res Mol Brain Res       Date:  2000-03-10

10.  Mu-opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1.

Authors:  M Connor; A Schuller; J E Pintar; M J Christie
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

View more
  42 in total

1.  Signaling cascades for δ-opioid receptor-mediated inhibition of GABA synaptic transmission and behavioral antinociception.

Authors:  Zhi Zhang; Zhizhong Z Pan
Journal:  Mol Pharmacol       Date:  2011-12-05       Impact factor: 4.436

2.  Chronic methadone treatment shows a better cost/benefit ratio than chronic morphine in mice.

Authors:  Johan Enquist; Madeline Ferwerda; Laura Milan-Lobo; Jennifer L Whistler
Journal:  J Pharmacol Exp Ther       Date:  2011-11-07       Impact factor: 4.030

3.  How to design an opioid drug that causes reduced tolerance and dependence.

Authors:  Amy Chang Berger; Jennifer L Whistler
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

4.  Rewarding morphine-induced synaptic function of delta-opioid receptors on central glutamate synapses.

Authors:  Bihua Bie; Wei Zhu; Zhizhong Z Pan
Journal:  J Pharmacol Exp Ther       Date:  2009-01-23       Impact factor: 4.030

5.  Extracellular signal-regulated kinase 1/2 activation counteracts morphine tolerance in the periaqueductal gray of the rat.

Authors:  Tara A Macey; Erin N Bobeck; Deborah M Hegarty; Sue A Aicher; Susan L Ingram; Michael M Morgan
Journal:  J Pharmacol Exp Ther       Date:  2009-08-14       Impact factor: 4.030

Review 6.  Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction.

Authors:  M J Christie
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

7.  Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia.

Authors:  L Gendron; J E Pintar; C Chavkin
Journal:  Neuroscience       Date:  2007-10-05       Impact factor: 3.590

8.  Delta opioid receptors presynaptically regulate cutaneous mechanosensory neuron input to the spinal cord dorsal horn.

Authors:  Rita Bardoni; Vivianne L Tawfik; Dong Wang; Amaury François; Carlos Solorzano; Scott A Shuster; Papiya Choudhury; Chiara Betelli; Colleen Cassidy; Kristen Smith; Joriene C de Nooij; Françoise Mennicken; Dajan O'Donnell; Brigitte L Kieffer; C Jeffrey Woodbury; Allan I Basbaum; Amy B MacDermott; Grégory Scherrer
Journal:  Neuron       Date:  2014-02-27       Impact factor: 17.173

9.  Mu-opioid receptors selectively regulate basal inhibitory transmission in the central amygdala: lack of ethanol interactions.

Authors:  Maeng-Hee Kang-Park; Brigitte L Kieffer; Amanda J Roberts; Marisa Roberto; Samuel G Madamba; George Robert Siggins; Scott D Moore
Journal:  J Pharmacol Exp Ther       Date:  2008-10-14       Impact factor: 4.030

10.  Coexpression of alpha 2A-adrenergic and delta-opioid receptors in substance P-containing terminals in rat dorsal horn.

Authors:  Maureen S Riedl; Stephen A Schnell; Aaron C Overland; Anne-Julie Chabot-Doré; Anna M Taylor; Alfredo Ribeiro-da-Silva; Robert P Elde; George L Wilcox; Laura S Stone
Journal:  J Comp Neurol       Date:  2009-04-01       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.